Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR)
The effects of the PPARγ
antagonist GW9662 (1 μM,
(a), and (b)) and the protein synthesis inhibitor, cycloheximide (10 μM, (c), and (d)) on vasorelaxation to anandamide and
NADA. Data are given as means with
error bars representing SEM.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.